References
1. Basso C, Corrado D, Bauce B, Thiene G. Arrhythmogenic Right
Ventricular Cardiomyopathy. Circ Arrhythm Electrophysiol .
2012;5:1233–1246.
2. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA,
Calkins H, Corrado D, Cox MGPJ, Daubert JP, Fontaine G, Gear K, Hauer R,
Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DMY, Steinberg
JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W.
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia:
Proposed Modification of the Task Force Criteria. Circulation .
2010;121:1533–1541.
3. Philips B, Madhavan S, James C, Tichnell C, Murray B, Needleman M,
Bhonsale A, Nazarian S, Laurita KR, Calkins H, Tandri H. High prevalence
of catecholamine-facilitated focal ventricular tachycardia in patients
with arrhythmogenic right ventricular dysplasia/cardiomyopathy.Circ Arrhythm Electrophysiol . 2013;6:160–166.
4. Cadrin-Tourigny J, Bosman LP, Nozza A, Wang W, Tadros R, Bhonsale A,
Bourfiss M, Fortier A, Lie ØH, Saguner AM, Svensson A, Andorin A,
Tichnell C, Murray B, Zeppenfeld K, van den Berg MP, Asselbergs FW,
Wilde AAM, Krahn AD, Talajic M, Rivard L, Chelko S, Zimmerman SL, Kamel
IR, Crosson JE, Judge DP, Yap S-C, van der Heijden JF, Tandri H,
Jongbloed JDH, Guertin M-C, van Tintelen JP, Platonov PG, Duru F, Haugaa
KH, Khairy P, Hauer RNW, Calkins H, Te Riele ASJM, James CA. A new
prediction model for ventricular arrhythmias in arrhythmogenic right
ventricular cardiomyopathy. Eur Heart J . 2019;40:1850–1858.
5. Santangeli P, Zado ES, Supple GE, Haqqani HM, Garcia FC, Tschabrunn
CM, Callans DJ, Lin D, Dixit S, Hutchinson MD, Riley MP, Marchlinski FE.
Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in
Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.Circ Arrhythm Electrophysiol . 2015;8:1413–1421.
6. Berruezo A, Fernández-Armenta J, Mont L, Zeljko H, Andreu D, Herczku
C, Boussy T, Tolosana JM, Arbelo E, Brugada J. Combined Endocardial and
Epicardial Catheter Ablation in Arrhythmogenic Right Ventricular
Dysplasia Incorporating Scar Dechanneling Technique. Circ Arrhythm
Electrophysiol . 2012;5:111–121.
7. Marcus GM, Glidden DV, Polonsky B, Zareba W, Smith LM, Cannom DS,
Estes III NAM, Marcus F, Scheinman MM. Efficacy of Antiarrhythmic Drugs
in Arrhythmogenic Right Ventricular Cardiomyopathy: A Report From the
North American ARVC Registry. J Am Coll Cardiol .
2009;54:609–615.
8. Dalal D, Jain R, Tandri H, Dong J, Eid SM, Prakasa K, Tichnell C,
James C, Abraham T, Russell SD, Sinha S, Judge DP, Bluemke DA, Marine
JE, Calkins H. Long-term efficacy of catheter ablation of ventricular
tachycardia in patients with arrhythmogenic right ventricular
dysplasia/cardiomyopathy. J Am Coll Cardiol . 2007;50:432–440.
9. Marchlinski FE. Electroanatomic Substrate and Outcome of Catheter
Ablative Therapy for Ventricular Tachycardia in Setting of Right
Ventricular Cardiomyopathy. Circulation . 2004;110:2293–2298.
10. Verma A, Kilicaslan F, Schweikert RA, Tomassoni G, Rossillo A,
Marrouche NF, Ozduran V, Wazni OM, Elayi SC, Saenz LC, Minor S, Cummings
JE, Burkhardt JD, Hao S, Beheiry S, Tchou PJ, Natale A. Short- and
Long-Term Success of Substrate-Based Mapping and Ablation of Ventricular
Tachycardia in Arrhythmogenic Right Ventricular Dysplasia.Circulation . 2005;111:3209–3216.
11. Garcia FC, Bazan V, Zado ES, Ren J-F, Marchlinski FE. Epicardial
substrate and outcome with epicardial ablation of ventricular
tachycardia in arrhythmogenic right ventricular
cardiomyopathy/dysplasia. Circulation . 2009;120:366–375.
12. Berruezo A, Fernández-Armenta J, Mont L, Zeljko H, Andreu D, Herczku
C, Boussy T, Tolosana JM, Arbelo E, Brugada J. Combined endocardial and
epicardial catheter ablation in arrhythmogenic right ventricular
dysplasia incorporating scar dechanneling technique. Circ Arrhythm
Electrophysiol . 2012;5:111–121.
13. Bai R, Di Biase L, Shivkumar K, Mohanty P, Tung R, Santangeli P,
Saenz LC, Vacca M, Verma A, Khaykin Y, Mohanty S, Burkhardt JD, Hongo R,
Beheiry S, Dello Russo A, Casella M, Pelargonio G, Santarelli P, Sanchez
J, Tondo C, Natale A. Ablation of ventricular arrhythmias in
arrhythmogenic right ventricular dysplasia/cardiomyopathy:
arrhythmia-free survival after endo-epicardial substrate based mapping
and ablation. Circ Arrhythm Electrophysiol . 2011;4:478–485.
14. Yoshida K, Liu T-Y, Scott C, Hero A, Yokokawa M, Gupta S, Good E,
Morady F, Bogun F. The value of defibrillator electrograms for
recognition of clinical ventricular tachycardias and for pace mapping of
post-infarction ventricular tachycardia. J Am Coll Cardiol .
2010;56:969–979.
15. Santangeli P, Alcalde O, Zado ES, Callans DJ, Marchlinski FE.
Spatial resolution of defibrillator electrograms to detect distinct exit
sites of scar-related ventricular tachycardia. Pacing Clin
Electrophysiol PACE . 2014;37:1256–1264.
16. Tung Roderick, Mathuria Nilesh, Michowitz Yoav, Yu Ricky, Buch Eric,
Bradfield Jason, Mandapati Ravi, Wiener Isaac, Boyle Noel, Shivkumar
Kalyanam. Functional Pace-Mapping Responses for Identification of
Targets for Catheter Ablation of Scar-Mediated Ventricular Tachycardia.Circ Arrhythm Electrophysiol . 2012;5:264–272.
17. Philips B, Madhavan S, James C, Tichnell C, Murray B, Dalal D,
Bhonsale A, Nazarian S, Judge DP, Russell SD, Abraham T, Calkins H,
Tandri H. Outcomes of catheter ablation of ventricular tachycardia in
arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ
Arrhythm Electrophysiol . 2012;5:499–505.
18. Müssigbrodt A, Dinov B, Bertagnoli L, Sommer P, Richter S,
Breithardt OA, Rolf S, Bollmann A, Hindricks G, Arya A. Precordial QRS
amplitude ratio predicts long-term outcome after catheter ablation of
electrical storm due to ventricular tachycardias in patients with
arrhythmogenic right ventricular cardiomyopathy. J
Electrocardiol . 2015;48:86–92.
19. Wei W, Liao H, Xue Y, Fang X, Huang J, Liu Y, Deng H, Liang Y, Liao
Z, Liu F, Lin W, Zhan X, Wu S. Long-Term Outcomes of Radio-Frequency
Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic
Right Ventricular Cardiomyopathy: A Single Center Experience. PLOS
ONE . 2017;12:e0169863.
20. Santangeli P, Tung R, Xue Y, Chung F-P, Lin Y-J, Di Biase L, Zhan X,
Lin C-Y, Wei W, Mohanty S, Burkhardt DJ, Zado ES, Callans DJ,
Marchlinski FE, Wu S, Chen S-A, Natale A. Outcomes of Catheter Ablation
in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background
Implantable Cardioverter Defibrillator Therapy. JACC Clin
Electrophysiol . 2019;5:55–65.
21. Mahida S, Venlet J, Saguner AM, Kumar S, Baldinger SH, AbdelWahab A,
Tedrow UB, Castelletti S, Pantazis A, John RM, McKenna WJ, Lambiase PD,
Duru F, Sapp JL, Zeppenfeld K, Stevenson WG. Ablation compared with drug
therapy for recurrent ventricular tachycardia in arrhythmogenic right
ventricular cardiomyopathy: Results from a multicenter study.Heart Rhythm . 2019;16:536–543.
22. Mathew S, Saguner AM, Schenker N, Kaiser L, Zhang P, Yashuiro Y,
Lemes C, Fink T, Maurer T, Santoro F, Wohlmuth P, Reißmann B, Heeger CH,
Tilz R, Wissner E, Rillig A, Metzner A, Kuck K, Ouyang F. Catheter
Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic
Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach.J Am Heart Assoc [Internet]. 2019 [cited 2021 Mar 5];8.
Available from: https://www.ahajournals.org/doi/10.1161/JAHA.118.010365
23. Lin C, Chung F, Kuo L, Lin Y, Chang S, Lo L, Hu Y, Tuan T, Chao T,
Liao J, Chang T, Yamada S, Te ALD, Huang T, Chen S. Characteristics of
recurrent ventricular tachyarrhythmia after catheter ablation in
patients with arrhythmogenic right ventricular cardiomyopathy. J
Cardiovasc Electrophysiol . 2019;30:582–592.
Table. Principal studies documenting the efficacy of
endo-epicardial catheter ablation of VT in ARVC.